# Ceftaroline China Pharmacokinetics Study

> **NCT01458743** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ceftaroline
- **DRUG:** Ceftaroline

## Key facts

- **NCT ID:** NCT01458743
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458743, "Ceftaroline China Pharmacokinetics Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01458743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*